“…Follow-up studies have failed to reveal a significant difference in survival with regard to palliation strategy 1 year after stage I [66,67]. This has been confirmed, with more recent results showing equivalent 1-year survival in both groups [48,61,75]. However, the Giessen group reported outstanding results after hybrid palliation, with survival of 84% at 1 year, 78% at 2 years, 77.8% at 10 years, and 77% at 15 years [13,51].…”